Arotech Corp. (NASDAQ:ARTX) Director Kenneth W. Cappell acquired 9,000 shares of the business’s stock in a transaction on Friday, November 18th. The shares were purchased at an average price of $3.23 per share, with a total value of $29,070.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Kenneth W. Cappell also recently made the following trade(s):

  • On Wednesday, November 16th, Kenneth W. Cappell bought 11,000 shares of Arotech Corp. stock. The shares were bought at an average price of $3.34 per share, for a total transaction of $36,740.00.

Arotech Corp. (NASDAQ:ARTX) traded up 3.03% on Tuesday, reaching $3.40. The company had a trading volume of 113,996 shares. The stock has a 50 day moving average price of $3.01 and a 200 day moving average price of $2.90. The stock’s market capitalization is $89.13 million. Arotech Corp. has a 52-week low of $1.60 and a 52-week high of $4.13.

A number of hedge funds and other institutional investors have recently modified their holdings of ARTX. Northern Trust Corp boosted its position in shares of Arotech Corp. by 0.3% in the third quarter. Northern Trust Corp now owns 41,856 shares of the company’s stock worth $124,000 after buying an additional 128 shares during the period. TFS Capital LLC bought a new position in shares of Arotech Corp. during the second quarter worth about $138,000. Spark Investment Management LLC boosted its position in shares of Arotech Corp. by 510.8% in the second quarter. Spark Investment Management LLC now owns 158,800 shares of the company’s stock worth $446,000 after buying an additional 132,800 shares during the period. Cannell Capital LLC bought a new position in shares of Arotech Corp. during the second quarter worth about $938,000. Finally, Oxford Asset Management bought a new position in shares of Arotech Corp. during the second quarter worth about $971,000. 13.68% of the stock is owned by institutional investors.

Several research analysts have recently weighed in on ARTX shares. Zacks Investment Research cut Arotech Corp. from a “hold” rating to a “sell” rating in a report on Thursday, August 11th. B. Riley reiterated a “buy” rating and issued a $4.50 price objective on shares of Arotech Corp. in a report on Sunday, November 13th.

Arotech Corp. Company Profile

Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division.

5 Day Chart for NASDAQ:ARTX

Receive News & Stock Ratings for Arotech Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech Corp. and related stocks with our FREE daily email newsletter.